Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus

Viruses
Juan-Carlos SaizMiguel A Martín-Acebes

Abstract

Zika virus (ZIKV), a mosquito-borne flavivirus, was an almost neglected pathogen until its introduction in the Americas in 2015, where it has been responsible for a threat to global health, causing a great social and sanitary alarm due to its increased virulence, rapid spread, and an association with severe neurological and ophthalmological complications. Currently, no specific antiviral therapy against ZIKV is available, and treatments are palliative and mainly directed toward the relief of symptoms, such as fever and rash, by administering antipyretics, anti-histamines, and fluids for dehydration. Nevertheless, lately, search for antivirals has been a major aim in ZIKV investigations. To do so, screening of libraries from different sources, testing of natural compounds, and repurposing of drugs with known antiviral activity have allowed the identification of several antiviral candidates directed to both viral (structural proteins and enzymes) and cellular elements. Here, we present an updated review of current knowledge about anti-ZIKV strategies, focusing on host-directed antivirals as a realistic alternative to combat ZIKV infection.

References

Jan 7, 1998·Journal of Virology·G KunoC B Cropp
May 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·S CrottyR Andino
Oct 5, 2001·Expert Opinion on Pharmacotherapy·N J Snell
Feb 8, 2003·Annual Review of Biophysics and Biomolecular Structure·R Michael Garavito, Anne M Mulichak
Sep 1, 1952·Transactions of the Royal Society of Tropical Medicine and Hygiene·G W A DICKA J HADDOW
Dec 21, 2004·Nature Reviews. Microbiology·Suchetana MukhopadhyayMichael G Rossmann
Feb 9, 2007·Journal of Neurochemistry·Jason P SarkeyEvan B Stubbs
Apr 22, 2009·Cell Host & Microbe·Maria-Dolores Fernandez-GarciaAli Amara
Jun 12, 2009·The New England Journal of Medicine·Mark R DuffyEdward B Hayes
Nov 3, 2009·Amino Acids·Karin StiasnyFranz X Heinz
Sep 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nicholas S HeatonGlenn Randall
Mar 30, 2012·PLoS Pathogens·Rushika PereraRichard J Kuhn
Jun 12, 2012·Virus Research·Angela Vázquez-CalvoMiguel A Martín-Acebes
Oct 8, 2013·PLoS Pathogens·Marianne Lucas-HouraniPierre-Olivier Vidalain
Feb 13, 2014·Viruses·Manoj N Krishnan, Mariano A Garcia-Blanco
Aug 27, 2014·Current Opinion in Virology·Luis Menéndez-Arias, Douglas D Richman
Dec 23, 2014·Emerging Infectious Diseases·Ann-Claire GourinatMyrielle Dupont-Rouzeyrol
Feb 26, 2015·The Journal of General Virology·Justin A RobyAlexander A Khromykh
Mar 25, 2015·Trends in Cardiovascular Medicine·Lionel H Opie
Nov 4, 2015·Antiviral Research·Valerie A VillarealPriscilla L Yang
Nov 4, 2015·BMC Infectious Diseases·Cheikh Tidiane DiagneMawlouth Diallo
Apr 1, 2016·Clinical Microbiology Reviews·Didier Musso, Duane J Gubler
Apr 12, 2016·Science·Patricia P GarcezStevens K Rehen
Apr 19, 2016·Nature Structural & Molecular Biology·Hao SongGeorge F Gao
Apr 20, 2016·Nature·Victor A KostyuchenkoShee-Mei Lok
May 6, 2016·Frontiers in Microbiology·Juan-Carlos SaizMiguel A Martín-Acebes
May 24, 2016·Cell Host & Microbe·Alesha GrantAdolfo García-Sastre
Jun 9, 2016·Cell Reports·George SavidisAbraham L Brass
Jun 10, 2016·Nature·Fernanda R CugolaPatricia C B Beltrão-Braga
Jul 12, 2016·Nature Structural & Molecular Biology·Rinku JainAneel K Aggarwal
Aug 2, 2016·Cell Host & Microbe·Nicholas J BarrowsMariano A Garcia-Blanco
Aug 19, 2016·Journal of Virology·Bryan C MounceMarco Vignuzzi

❮ Previous
Next ❯

Citations

Mar 22, 2019·Journal of Virology·Angelica Cifuentes KottkampKenneth A Stapleford
Jun 21, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vanessa Shi Li GohJustin Jang Hann Chu
Apr 26, 2019·Proceedings of the National Academy of Sciences of the United States of America·Yun LiRudolf Jaenisch
Sep 5, 2019·Pharmaceuticals·Juan-Carlos Saiz
Sep 21, 2019·Current Drug Targets·Dhurvas Chandrasekaran DineshEvžen Bouřa
Mar 17, 2019·Viruses·Luis Martinez-Sobrido, Fernando Almazán
Jun 11, 2019·Annual Review of Virology·Dawn M DudleyDavid H O'Connor
Aug 11, 2020·Frontiers in Microbiology·Cybele C GarcíaElsa B Damonte
Sep 27, 2020·Tropical Medicine and Infectious Disease·Nelly M SilvaIvo C Martins
Dec 2, 2020·Journal of Biomolecular Structure & Dynamics·Nirmitee MulgaonkarSandun Fernando
Dec 19, 2020·International Journal of Molecular Sciences·Ana-Belén Blázquez, Juan-Carlos Saiz
Jun 22, 2020·The Lancet Infectious Diseases·Patrick L IversenDavid L Saunders
Mar 7, 2021·Pathogens·Laura Albentosa-GonzálezAntonio Mas
Sep 4, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Parichehr Hassanzadeh
Jun 4, 2019·Microbes and Infection·Pauline FerrarisDorothée Missé
May 1, 2021·Viruses·Robert J GeraghtyLaurent F Bonnac
Jun 3, 2021·Viruses·Laura Albentosa-GonzálezAntonio Mas
Jul 30, 2020·Combinatorial Chemistry & High Throughput Screening·Mradul Mohan, Debapriya Bhattacharya

❮ Previous
Next ❯

Methods Mentioned

BETA
two-hybrid
glycosylation

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Antimicrobial Agents and Chemotherapy
Juan-Carlos Saiz, Miguel A Martín-Acebes
Virologica Sinica
Zhaoyang WangJing An
The Netherlands Journal of Medicine
M GoeijenbierC B E M Reusken
© 2022 Meta ULC. All rights reserved